These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10415659)

  • 21. Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia.
    Brooks JM; Sarter M; Bruno JP
    Neuropsychopharmacology; 2011 Nov; 36(12):2477-87. PubMed ID: 21814184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of cortical acetylcholine release by orexin A.
    Fadel J; Pasumarthi R; Reznikov LR
    Neuroscience; 2005; 130(2):541-7. PubMed ID: 15664710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats.
    Turchi J; Sarter M
    Brain Res Cogn Brain Res; 1997 Oct; 6(2):147-58. PubMed ID: 9450608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats.
    Kozak R; Martinez V; Young D; Brown H; Bruno JP; Sarter M
    Neuropsychopharmacology; 2007 Oct; 32(10):2074-86. PubMed ID: 17299502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic regulation of cortical acetylcholine release.
    Day J; Fibiger HC
    Synapse; 1992 Dec; 12(4):281-6. PubMed ID: 1465741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
    Li Z; Huang M; Ichikawa J; Dai J; Meltzer HY
    Neuropsychopharmacology; 2005 Nov; 30(11):1986-95. PubMed ID: 15900318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical cholinergic transmission and cortical information processing in schizophrenia.
    Sarter M; Nelson CL; Bruno JP
    Schizophr Bull; 2005 Jan; 31(1):117-38. PubMed ID: 15888431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific subtypes of cortical GABA interneurons contribute to the neurovascular coupling response to basal forebrain stimulation.
    Kocharyan A; Fernandes P; Tong XK; Vaucher E; Hamel E
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):221-31. PubMed ID: 17895909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prefrontal cortical modulation of acetylcholine release in posterior parietal cortex.
    Nelson CL; Sarter M; Bruno JP
    Neuroscience; 2005; 132(2):347-59. PubMed ID: 15802188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands.
    Moore H; Sarter M; Bruno JP
    Brain Res; 1993 Nov; 627(2):267-74. PubMed ID: 8298971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex.
    Détári L; Rasmusson DD; Semba K
    Prog Neurobiol; 1999 Jun; 58(3):249-77. PubMed ID: 10341363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Food-elicited increases in cortical acetylcholine release require orexin transmission.
    Frederick-Duus D; Guyton MF; Fadel J
    Neuroscience; 2007 Nov; 149(3):499-507. PubMed ID: 17928158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain.
    Holley LA; Turchi J; Apple C; Sarter M
    Psychopharmacology (Berl); 1995 Jul; 120(1):99-108. PubMed ID: 7480541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical acetylcholine, reality distortion, schizophrenia, and Lewy Body Dementia: too much or too little cortical acetylcholine?
    Sarter M; Bruno JP
    Brain Cogn; 1998 Dec; 38(3):297-316. PubMed ID: 9841788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascending cholinergic pathways: functional organization and implications for disease models.
    Wainer BH; Steininger TL; Roback JD; Burke-Watson MA; Mufson EJ; Kordower J
    Prog Brain Res; 1993; 98():9-30. PubMed ID: 7902596
    [No Abstract]   [Full Text] [Related]  

  • 36. Cognitive functions of the basal forebrain.
    Baxter MG; Chiba AA
    Curr Opin Neurobiol; 1999 Apr; 9(2):178-83. PubMed ID: 10322180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized cortex activation by the auditory midbrain: Mediation by acetylcholine and subcortical relays.
    Dringenberg HC; Sparling JS; Frazer J; Murdoch J
    Exp Brain Res; 2006 Sep; 174(1):114-23. PubMed ID: 16575576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orexin/hypocretin modulation of the basal forebrain cholinergic system: insights from in vivo microdialysis studies.
    Fadel J; Frederick-Duus D
    Pharmacol Biochem Behav; 2008 Aug; 90(2):156-62. PubMed ID: 18281084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented prefrontal acetylcholine release during challenged attentional performance.
    Kozak R; Bruno JP; Sarter M
    Cereb Cortex; 2006 Jan; 16(1):9-17. PubMed ID: 15788700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential control of cortical activity by the basal forebrain in rats: a role for both cholinergic and inhibitory influences.
    Jiménez-Capdeville ME; Dykes RW; Myasnikov AA
    J Comp Neurol; 1997 Apr; 381(1):53-67. PubMed ID: 9087419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.